Drug record
What four public record sets show for tirzepatide. Saved Nov 10, 2026.
| Shortage | Not on the FDA shortage list | Details |
|---|---|---|
| Pharmacy cost | Brand prices only, see table | Details |
| Medicare Part D, 2024 | $6.34 billion | Details |
| FDA recall records | 28 | Details |
Whether the FDA lists this drug as in short supply.
The list changes daily, and it covers the national supply. A pharmacy near you can be out of a drug that is not listed, or have one that is. See today's status.
The national average price retail pharmacies pay to buy it (NADAC).
| Product as surveyed | Type | Pharmacy pays | For 30 | Price since |
|---|---|---|---|---|
| MOUNJARO 10 MG/0.5 ML PEN | Brand | $538.76 per mL | — | Oct 21, 2026 |
| MOUNJARO 12.5 MG/0.5 ML PEN | Brand | $538.59 per mL | — | Oct 21, 2026 |
| MOUNJARO 15 MG/0.5 ML PEN | Brand | $538.57 per mL | — | Oct 21, 2026 |
| MOUNJARO 2.5 MG/0.5 ML PEN | Brand | $538.75 per mL | — | Oct 21, 2026 |
| MOUNJARO 5 MG/0.5 ML PEN | Brand | $538.70 per mL | — | Oct 21, 2026 |
| MOUNJARO 7.5 MG/0.5 ML PEN | Brand | $538.74 per mL | — | Oct 21, 2026 |
| ZEPBOUND 10 MG/0.5 ML PEN | Brand | $526.07 per mL | — | Oct 21, 2026 |
| ZEPBOUND 10 MG/DOSE (40 MG/2.4 ML) KWIKPEN | Brand | $281.78 per mL | — | Oct 21, 2026 |
| ZEPBOUND 12.5 MG/0.5 ML PEN | Brand | $525.83 per mL | — | Oct 21, 2026 |
| ZEPBOUND 12.5 MG/DOSE (50 MG/2.4 ML) KWIKPEN | Brand | $282.23 per mL | — | Oct 21, 2026 |
| ZEPBOUND 15 MG/0.5 ML PEN | Brand | $525.93 per mL | — | Oct 21, 2026 |
| ZEPBOUND 15 MG/DOSE (60 MG/2.4 ML) KWIKPEN | Brand | $281.68 per mL | — | Oct 21, 2026 |
| ZEPBOUND 2.5 MG/0.5 ML PEN | Brand | $526.23 per mL | — | Oct 21, 2026 |
| ZEPBOUND 2.5 MG/DOSE (10 MG/2.4 ML) KWIKPEN | Brand | $201.39 per mL | — | Oct 21, 2026 |
| ZEPBOUND 5 MG/0.5 ML PEN | Brand | $526.10 per mL | — | Oct 21, 2026 |
| ZEPBOUND 5 MG/DOSE (20 MG/2.4 ML) KWIKPEN | Brand | $201.20 per mL | — | Oct 21, 2026 |
| ZEPBOUND 7.5 MG/0.5 ML PEN | Brand | $526.04 per mL | — | Oct 21, 2026 |
| ZEPBOUND 7.5 MG/DOSE (30 MG/2.4 ML) KWIKPEN | Brand | $201.16 per mL | — | Oct 21, 2026 |
This is not your price. NADAC is the national average that retail pharmacies pay to buy the drug, from the Medicaid survey for the week of Nov 11, 2026. What you pay adds the pharmacy's markup and dispensing fee and depends on your insurance or any discount card. "For 30" is shown only for products priced per tablet or capsule. Brand prices here are before any rebates.
Medicare Part D spending by product, from the latest annual file (2024).
In 2024, Medicare Part D plans and their members paid $6.34 billion for the 2 products below.
| Product | 2024 spending | People | Per prescription | Per person, year | 2020 spending |
|---|---|---|---|---|---|
| Mounjaro Tirzepatide | $6.34 billion | 894,581 | $1,241.22 | $7,083.70 | — |
| Zepbound Tirzepatide | $387,343 | 245 | $1,097.29 | $1,580.99 | — |
Spending is the gross amount paid at the pharmacy by Part D plans and patients, before manufacturer rebates, which can be large for brand drugs. The same person can use more than one product, so people are not added up across rows. A dash means the file suppresses a small number or has no figure for that year.
Recalls reported to the FDA that name this drug.
The FDA has 28 recall records that name tirzepatide in the product description (1 Class I · 27 Class II). 28 are still marked ongoing.
Tirzepatide/Niacinamide 2mL vial (40 MG per Vial) Inj 20mg/2mg/mL, RX Only, Houston RX LLC, 15430 Vantage Parkway E STE 220, Houston, TX 77032.
Reason: Lack of assurance of sterility.
TIRZEPATIDE/CYANOCOBALAMIN 26/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936
Reason: Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
Tirzepatide Injection, 18mg/mL, 4 mL Sterile Multi-Dose Vial, Rx only, Apothecary Pharma, LLC, 1913 Evans Road, Cary, NC 27513, NDC 85091-001-18.
Reason: Lack of Assurance of Sterility
TIRZEPATIDE/CYANOCOBALAMIN 85/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936;
Reason: Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
TIRZEPATIDE/CYANOCOBALAMIN 64/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936
Reason: Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
TIRZEPATIDE/CYANOCOBALAMIN 76/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936
Reason: Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
TIRZEPATIDE 26 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936;
Reason: Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
Tirzepatide Inj, 15mg x 4, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-002-04.
Reason: Lack of Assurance of Sterility
Tirzepatide Inj, 10mg, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-002-03.
Reason: Lack of Assurance of Sterility
Tirzepatide Injection, 27 mg/3 mL (9 mg/mL), 3mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-209-03
Reason: Lack of Assurance of Sterility
Tirzepatide, 60mg/10 mL for Injection, 10mL vial lyophilized, all presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as manufactured for Extension Health and Synergy Wellness 60mg, 10mL vial lyophilized.
Reason: Lack of Assurance of Sterility
Tirzepatide + Niacinamide 4.4 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.
Reason: Lack of Processing Controls.
A recall covers specific lots from one company, not every bottle of the drug. Records include combination products and compounded versions that name this ingredient. Class I is the most serious: use could cause serious harm. Class II may cause temporary or reversible harm. Class III is unlikely to cause harm. To check a bottle, match the lot number on the label. See the live list. Do not stop a medicine because of a recall without asking your pharmacist.
These are saved records as of Nov 10, 2026; the sources update daily to yearly. For current figures open the live report for tirzepatide. This page is public-record information, not medical advice.